Head and Neck Neoplasms: Clinical Trials

8,397 trials for Head and Neck Neoplasms, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3295 completed, 1542 unknown, 1461 recruiting, 735 terminated. 2933 Phase 2, 1832 Not applicable, 1538 Phase 1, 727 Phase 3, 119 Early Phase 1.

By phase and status

PhaseTrialsStatus
Phase 22933Completed 1076, Unknown 510, Recruiting 498, Terminated 312, Active not recruiting 234, Not yet recruiting 185, Withdrawn 98, Enrolling by invitation 10, Suspended 10
Not applicable1832Completed 750, Unknown 364, Recruiting 325, Terminated 117, Not yet recruiting 112, Active not recruiting 77, Withdrawn 64, Enrolling by invitation 13, Suspended 10
Phase 11538Completed 656, Recruiting 251, Terminated 245, Unknown 145, Active not recruiting 129, Withdrawn 54, Not yet recruiting 46, Suspended 7, Enrolling by invitation 5
Phase 3727Completed 244, Recruiting 154, Unknown 151, Terminated 59, Active not recruiting 58, Not yet recruiting 41, Withdrawn 18, Enrolling by invitation 1, Suspended 1
Early Phase 1119Completed 43, Unknown 19, Recruiting 16, Terminated 16, Withdrawn 10, Not yet recruiting 8, Active not recruiting 6, Enrolling by invitation 1
Phase 4116Completed 49, Unknown 31, Recruiting 15, Terminated 7, Not yet recruiting 6, Active not recruiting 4, Withdrawn 3, Enrolling by invitation 1

Follow Head and Neck Neoplasms: new trials by email Literature Review of Head and Neck Neoplasms trials Research Report on Head and Neck Neoplasms

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
9-ING-41 Plus Carboplatin in Patients With Advanced, Metastatic Salivary Gland Carcinoma
9-ING-41, Carboplatin - Salivary Gland Carcinoma, Adenoid Cystic Carcinoma
Phase 2WithdrawnActuate Therapeutics Inc.2030-12-182022-02-22
Mapping Patient Decision-making in Thyroid Cancer
Decision navigation tool - Thyroid Cancer
Not applicableNot yet recruitingUniversity of California, Los Angeles502028-04-012026-07-24
Adaptive Neoadjuvant Therapy for Esophageal Cancer
Neoadjuvant concurrent chemoradiotherapy - Esophageal Carcinoma, Neoadjuvant Therapy
Not applicableEnrolling by invitationCancer Hospital Chinese Academy of Medical Science, Shenzhen Center432028-03-012025-05-25
Symptom Management to Improve Completion of Patient-reported Outcome Measures
Monitoring of PROMIS symptoms and physical function, Monitoring of additional symptoms and symptom self-management - Malignant Solid Neoplasm, Malignant Head and Neck Neoplasm
Not applicableNot yet recruitingHenry Ford Health System782027-10-012026-07-29
Pre-Clinic Visit Online Education for Thyroid Cancer
THRIVE, ACS "After a Thyroid Cancer Diagnosis" Flyer - Thyroid Cancer
Not applicableNot yet recruitingCedars-Sinai Medical Center602027-08-012026-09-01
Removing the Planning Tumor Volume From Radiation Therapy for the Treatment of Head and Neck Squamous Cell Carcinoma
Chemotherapy, Computed Tomography, Endoscopic Procedure - Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
Not applicableNot yet recruitingCity of Hope Medical Center302027-06-222026-11-09
The FORCE Trial Pilot: Fish Oil-enriched Nutrition for Radiotherapy in Cancer of the hEad and Neck
Nutrition counseling, Fresubin Supportan - Head &Amp;Amp; Neck Squamous Cell Carcinoma
Phase 1 / Phase 2Not yet recruitingAnna Arthur, PhD152027-06-012026-08-07
Trial of a Personalized and Adaptive Neoantigen Dose-Adjusted Vaccine Concurrently With Pembrolizumab
PANDA-VAC, Pembrolizumab - Squamous Cell Lung Cancer, Squamous Non-small Cell Lung Cancer
Phase 1SuspendedUNC Lineberger Comprehensive Cancer Center62027-05-202026-04-23
Chemo-embolization for Head and Neck Cancer
Cisplatin - SCCHN, Squamous Cell Carcinoma
Phase 2WithdrawnUniversity of Alabama at Birmingham2027-05-012025-04-27
A Ph2, Colchicine For Inflammatory Carotid Injury And Disease Evolution After Radiotherapy
Colchicine, Placebo - Head and Neck Cancer
Phase 2Not yet recruitingM.D. Anderson Cancer Center2502027-03-012026-10-05
Understanding the Role of MyCareGorithm as a Visual Digital Platforms in Cancer Treatment Education and Patient Comprehension of Oncology Treatment Plans
Survey - Head and Neck Cancer, Prostate Cancer
Not applicableNot yet recruitingM.D. Anderson Cancer Center942027-03-012026-10-01
Risk Factors of Jaw Osteoradionecrosis in Oral Cavity Cancer Patients Post-Radiotherapy
Osteoradionecrosis, Radiotherapy
Not yet recruitingAO Innovation Translation Center10002027-03-012026-09-23
Maximizing Quality of Life After Cancer Through Rehabilitation
TIMELY REHAB - Head and Neck Cancer, Hearing Loss
Not applicableNot yet recruitingVA Office of Research and Development742027-03-012026-06-03
Proactively Intervening On Early Cranial Nerve Injury As A Delayed Sequela Of Oropharyngeal Cancer: A Randomized Feasibility Clinical Trial For Pro-Habilitation (proNERVE RCT)
Prednisone, Ajovy, Manual Therapy - Cranial Nerve Injury, Oropharyngeal Cancer
Phase 1Not yet recruitingM.D. Anderson Cancer Center482027-03-012026-09-21
Stereotactic Body Radiation Therapy (SBRT) and Immunotherapy for Oligometastatic Esophageal Cancer
Stereotactic body radiation treatment (SBRT) - Esophageal Cancer
Phase 2Not yet recruitingAHS Cancer Control Alberta222027-03-012026-10-28
Sac-TMT in Salivary Gland Cancers
Sacituzumab Tirumotecan (Sac-TMT) - Salivary Gland Cancers, Adenoid Cystic Carcinoma of the Salivary Gland
Phase 2Not yet recruitingLatin American Cooperative Oncology Group642027-03-012026-11-10
Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma
Biospecimen Collection, Camonsertib, Computed Tomography - Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Recurrent Head and Neck Squamous Cell Carcinoma
Phase 1RecruitingNational Cancer Institute (NCI)392027-02-132026-10-29
Impact of Chronic MICROplastic Exposure on RADiotherapy of Head and Neck Cancer Patients: Clinical and Translational Oncology Study:
Head and Neck Cancer, Microplastic Exposure
Not yet recruitingUniversity of Kragujevac5002027-02-012026-11-06
ALDH2 Genetic Testing in East Asian Community
Genetic Test Results Return, Alcohol Flushing Education - Healthy Adult, Flushing
Not applicableNot yet recruitingNorthwestern University1002027-02-012026-10-28
Speed of Processing Training to Improve Cognitive Functioning and Driving Performance in Head and Neck Cancer Survivors
Speed of Processing Training, Home-Based Sham Training - Head and Neck Cancer (H&N)
Not applicableNot yet recruitingUniversity of Alabama at Birmingham302027-01-032026-10-02

Showing 20 of 8397. Sign in to see all of them.

Narrower conditions

Squamous Cell Carcinoma of Head and Neck (1959)  ·  Esophageal Neoplasms (1843)  ·  Thyroid Neoplasms (722)  ·  Stomach Neoplasms (677)  ·  Nasopharyngeal Carcinoma (651)  ·  Esophageal Squamous Cell Carcinoma (626)  ·  Carcinoma, Non-Small-Cell Lung (580)  ·  Neoplasms (480)  ·  Breast Neoplasms (470)  ·  Lung Neoplasms (446)  ·  Mouth Neoplasms (443)  ·  Colorectal Neoplasms (440)  ·  Pancreatic Neoplasms (379)  ·  Melanoma (369)

Broader conditions

Neoplasms by Site (8370)  ·  Neoplasms (7917)  ·  Neoplasms by Histologic Type (4105)  ·  Neoplasms, Glandular and Epithelial (3935)  ·  Carcinoma (3730)  ·  Digestive System Diseases (2913)  ·  Gastrointestinal Diseases (2843)  ·  Digestive System Neoplasms (2781)  ·  Gastrointestinal Neoplasms (2630)  ·  Carcinoma, Squamous Cell (2380)  ·  Esophageal Diseases (2365)  ·  Stomatognathic Diseases (1971)  ·  Endocrine System Diseases (1517)  ·  Endocrine Gland Neoplasms (1499)

Interventions

Cisplatin (866)  ·  Radiotherapy (509)  ·  pembrolizumab (398)  ·  Fluorouracil (354)  ·  Paclitaxel (338)  ·  Cetuximab (307)  ·  Carboplatin (305)  ·  Docetaxel (305)  ·  Radiotherapy, Intensity-Modulated (234)  ·  Nivolumab (171)  ·  Drug Therapy (159)  ·  Radiation (148)  ·  Capecitabine (143)  ·  Gemcitabine (140)  ·  Surgical Procedures, Operative (122)

Sponsors

Sun Yat-sen University (282)  ·  National Cancer Institute (NCI) (216)  ·  M.D. Anderson Cancer Center (172)  ·  Memorial Sloan Kettering Cancer Center (138)  ·  Fudan University (113)  ·  National Taiwan University Hospital (88)  ·  University Health Network, Toronto (71)  ·  Dana-Farber Cancer Institute (70)  ·  Washington University School of Medicine (62)  ·  Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (59)  ·  Mayo Clinic (56)  ·  Cancer Institute and Hospital, Chinese Academy of Medical Sciences (49)  ·  West China Hospital (47)  ·  Tianjin Medical University Cancer Institute and Hospital (46)  ·  Zhejiang Cancer Hospital (46)

Countries

United States (3124)  ·  China (1929)  ·  France (620)  ·  Canada (453)  ·  United Kingdom (400)  ·  Taiwan (370)  ·  Italy (361)  ·  Spain (337)  ·  Germany (309)  ·  South Korea (305)  ·  Netherlands (276)  ·  Belgium (240)  ·  Australia (218)  ·  Japan (188)  ·  Denmark (152)

Top investigators

Jun Ma, M.D. (14)  ·  Lillian Siu, MD (14)  ·  Barbara Murphy, MD (13)  ·  Nancy Lee, MD (13)  ·  David H. Ilson, MD, PhD (11)

Results publications

PMID 25057165, PMID 31150573, PMID 33538338, PMID 30207593, PMID 26808342, PMID 40668552, PMID 22646630, PMID 36990609, PMID 26254683, PMID 27686945, PMID 28837405, PMID 29584545, PMID 30089078, PMID 31679945, PMID 34341578, PMID 37650478, PMID 37934000, PMID 10071296, PMID 12361079, PMID 12988177, PMID 15128893, PMID 15172646, PMID 15459926, PMID 15979480, PMID 16467544, PMID 17960012, PMID 18309943, PMID 18457329, PMID 19097774, PMID 19260131, PMID 19564532, PMID 20014446, PMID 20299249, PMID 20623305, PMID 21541945, PMID 21684205, PMID 22108231, PMID 22422558, PMID 22864015, PMID 23720248, PMID 24817237, PMID 25081901, PMID 26313683, PMID 26884585, PMID 27718784, PMID 28434660, PMID 30213452, PMID 30350310, PMID 31178151, PMID 31420360

NIH funding

2023 (59), 2019 (35), 2017 (31), 2016 (28), 2014 (22), 2025 (22), P30CA068485 (22), 2015 (21), U10CA032102 (21), 2018 (19), P30CA016672 (17), P30CA012197 (15), U10CA021115 (15), U10CA180868 (15), P30CA006516 (13)